EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Adverse effects of early phenobarbital administration in term newborns with perinatal asphyxia


Tropical Medicine & International Health 3(7): 592-595
Adverse effects of early phenobarbital administration in term newborns with perinatal asphyxia
Taking advantage of the lack of consensus in our neonatal unit regarding the early (prior to the onset of signs of hypoxic-ischaemic encephalopathy) administration of phenobarbital to term infants with perinatal asphyxia, we evaluated the possible cerebral sparing effect of phenobarbital by doing a retrospective case-control analysis. Fifty-seven infants who received 10 mg/kg loading dose of phenobarbital within one hour following resuscitation and before the onset of signs of hypoxic-ischaemic encephalopathy were compared with 91 infants who did not to determine the effect of early phenobarbital on the incidence of subsequent seizures, and mortality in the perinatal period. Early phenobarbital was associated with a threefold (P < 0.025) increase in the incidence of subsequent seizures, and consequently a trend towards increased mortality. Seizures per se were associated with almost a 20-fold increase in mortality (P < 0.0001). These findings suggest that early phenobarbital administration may produce adverse rather than beneficial effects following asphyxia. Because this is an observational study; these results need to be confirmed by appropriate randomized trials in similar clinical settings.

(PDF same-day service: $19.90)

Accession: 029925642

PMID: 9705195

DOI: 10.1046/j.1365-3156.1998.00274.x



Related references

High-Dose Phenobarbital and Erythropoietin for the Treatment of Perinatal Asphyxia in Term Newborns. Pediatrics International, 2013

High-dose phenobarbital or erythropoietin for the treatment of perinatal asphyxia in term newborns. Pediatrics International 55(5): 589-593, 2014

Question 1: Phenobarbital for preventing mortality and morbidity in full-term newborns with perinatal asphyxia in a resource-poor setting. Archives of Disease in Childhood 100(10): 1000-1003, 2016

Effects of vitamin C in full-term newborns with perinatal asphyxia. Boletin de Estudios Medicos y Biologicos Universidad Nacional Autonoma de Mexico 44(1-4): 93-94, 1996

The prognostic value of multivoxel magnetic resonance spectroscopy determined metabolite levels in white and grey matter brain tissue for adverse outcome in term newborns following perinatal asphyxia. European Radiology 22(4): 772-778, 2012

Increased inspired oxygen in the first hours of life is associated with adverse outcome in newborns treated for perinatal asphyxia with therapeutic hypothermia. Journal of Pediatrics 161(3): 409-416, 2013

The value of ultrasonography and Doppler sonography in prognosticating long-term outcomes among full-term newborns with perinatal asphyxia. Medicina 50(2): 100-110, 2016

Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 58(4): 542-548, 2002

Effect of Phenobarbital on Nitric Oxide Level in Term Newborn Infants with Perinatal Asphyxia. Oman Medical Journal 31(5): 332-335, 2016

Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database of Systematic Reviews (): Cd001240-Cd001240, 2007